InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Holdbrook Mark J.. Officer active across 1 company, notably Tarsus Pharmaceuticals, Inc.. Aggregated, 2 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €2k. Activity tracked since 17 March 2023. The latest transaction was filed on 17 March 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations